BMS-564929

Ergogenic / SARM

Anabolic muscle/bone research positioning

Reading this compound Reference only

Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.

Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.

Mechanism & Use

Compound type: SARM
Primary mechanism: Selective androgen receptor agonism
Primary market use: Muscle wasting research

Pharmacology

Molecular weight (Da): 419.78
Oral bioavailability: Oral/preclinical; high in animal models
Half-life: ~8-14 h preclinical
Route tags: Route-dependent / verify
Evidence level: Preclinical
Clinical status: Research; prohibited in sport
Value-for-money score: 3 / 10

Reported protocol signal

No popular protocol verified yet; keep as reference compound until protocol signal is added.

For orientation only. See disclaimer — always consult a licensed clinician before use.

Notes

Potent preclinical SARM; no approved human use

Sources

https://pubchem.ncbi.nlm.nih.gov/compound/BMS-564929